High-dose inhaled nitric oxide shows early promise as a potential antimicrobial therapy

Overuse of antibiotics has accelerated the development of bacterial resistance to conventional drugs, a global health crisis ...

Polarean Expands Xenon MRI Platform into Cardiopulmonary Drug Development with Multi-Center PH-ILD Study

DURHAM, NC and LONDON, Jan. 20, 2026 (GLOBE NEWSWIRE) -- Polarean, a commercial-stage medical imaging company advancing functional MRI of the lungs, today announced the expansion of its Xenon MRI ...
The Pharma Letter

Kindeva Drug Delivery

A global contract development and manufacturing organization focused on drug-device combination products. The company ...
Business Wire

Qnovia Enters Collaboration with University of Virginia to Advance Inhaled Drug Candidates for Treating Infectious Diseases

RICHMOND, Va.--(BUSINESS WIRE)--Qnovia, Inc., a pharma company developing inhaled therapeutics across a variety of indication areas, today announced it has entered into a drug development ...

Transpire Bio Announces Completion of First Human Dosing in Clinical Trial Using its Novel Inhalation Formulation

Transpire Bio, an integrated clinical-stage biopharmaceutical company focused on developing inhaled therapeutics for pulmonary and systemic diseases, today announced that it has successfully dosed the ...
Nasdaq

Innovative Inhaled Drug Delivery Developer Aerami Therapeutics to Merge with Special Purpose Acquisition Company FoxWayne Enterprises Acquisition Corp. to Become Public Company

AER-901, Aerami’s proprietary inhaled, nebulized formulation of imatinib, targeted to advance in 2022 into a Phase 2/3 clinical trial for PAH Aerami expected to file for 510(k) clearance in 2022 for ...
Reuters

New inhaled drug protects from flu in single dose

WASHINGTON (Reuters) - A single dose of an experimental influenza drug saves more mice from H5N1 avian influenza than the preferred drug Tamiflu, researchers reported on Thursday, and can also protect ...
McKnight's Long-Term Care News

Alexza surges after inhaled antipsychotic drug gets support

Stock prices for Alexza Pharmaceuticals Inc. recently surged by 25% to 78 cents. This came after the Food and Drug Administration’s Psychopharmacologic Drugs Advisory Committee conditionally backed ...
Science Daily

Inhalation drug prevents severe pneumonia: Sugar molecule accurately delivers RNA drug to target cells

Overly active immune cells are often behind lung damage in diseases such as Covid-19. Researchers have developed an RNA agent for a lung spray that slows the activity of these cells, known as ...
New Atlas

Inhaled drug reduces lung damage by targeting overactive immune cells

Researchers have developed an inhalable RNA-based drug that targets the overactive white blood cells that cause lung damage during severe infection, reducing inflammation and scarring. With human ...
MarketWatch

Lonza Group, Catalent, and Recipharm Lead the $12.5 Billion Inhaled Drugs Contract Manufacturing Market, 2025-2033: Insights by Service, Product, End-Use and Region ...

The "Inhaled Drugs Contract Manufacturing Market Forecast to 2033" has been added to ResearchAndMarkets.com's offering. The global inhaled drugs contract manufacturing market is experiencing ...
Reuters

Evoke Pharma's inhaled gastro drug better than oral generic

(Reuters) - Evoke Pharma Inc said its inhaled version of a generic gastrointestinal drug was found to be superior in managing symptoms of bowel disease compared with the existing oral treatment, ...